Are flu vaccines worth the effort, year after year?
GLENN ELLIS | 2/29/2016, 12:27 p.m.
George Curry Media
The flu (or common flu) is a viral infection that is spread from person to person in secretions of the nose and lungs, for example when sneezing. Medically, it is referred to as influenza, a respiratory infection that develops primarily in the lungs. Respiratory infections caused by other viruses often are called flu, but this is incorrect. Influenza usually causes higher fever, more malaise and severe body aches than other respiratory infections. Although other viruses may cause these symptoms, they do so less commonly than the flu.
Influenza viruses are divided into three types, designated A, B and C. Influenza types A and B are responsible for epidemics of respiratory illness that occur almost every winter. Influenza type C usually causes either a very mild respiratory illness or no symptoms at all; it does not cause epidemics and does not have the severe “public-health” impact of influenza types A and B. Type A viruses are divided into subtypes and are named based on differences in two viral surface proteins called hemagglutinin (H) and neuraminidase (N). There are 16 known H subtypes and nine known N subtypes.
The flu is a very common illness. Every year in the United States, on average 5 percent to 20 percent of the population gets the flu, more than 200,000 people are hospitalized from flu complications, and about 36,000 people die from the flu or its complications.
Each year, the influenza virus can change slightly, making the vaccine used in previous years ineffective. A new vaccine must be prepared every year, which will be effective against the expected type of influenza virus. Every year, federal health agency officials try to guess which three flu strains are most likely to be prevalent in the U.S. the following year to determine which strains will be included in next year’s flu vaccine. If they guess right, the vaccine is thought to be 70 to 80 percent effective in temporarily preventing the flu of the season in healthy persons less than 65 years old (the effective rate drops to 30 to 40 percent in those over 65 years old but the vaccine is thought to be 50 percent to 60 percent effective in preventing hospitalization and pneumonia and 80 percent effective in preventing death from the flu in the over 65 age group).
However, sometimes health officials do not correctly predict which flu strains will be most prevalent and the vaccine’s effectiveness is much lower for that year. The trick is to be able to predict which influenza viruses are going to cause infection and to prepare a vaccine against those viruses. Usually, scientists can predict accurately which types of influenza virus will cause infections and prepare an appropriate vaccine. The viruses that are used to prepare flu vaccine are grown in hens’ eggs.
Traditionally, we’re given influenza vaccines during a tight period of time in October and November of each year, mostly because we were trying to focus on high-risk groups.
The most frequent side effects are pain, redness and swelling at the injection site (10-64 percent) lasting one to two days, and systemic side effects such as headache, fever and malaise in about 5 percent of persons who are vaccinated.